Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the HER2-positive subgroup

Affiliation auteurs!!!! Error affiliation !!!!
TitreLong-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the HER2-positive subgroup
Type de publicationJournal Article
Year of Publication2019
AuteursD'Hondt V., Canon J.-L, Roca L., Levy C., Pierga J.-Y, Le Du F., Campone M., Desmoulins I., Viens P., Debled M., Ferrero J.-M, Serin D., Bessard A.-CHardy, Brain E., Dohollou N., Orfeuvre H., Lemonnier J., Roche H., Delaloge S., Dalenc F.
JournalANNALS OF ONCOLOGY
Volume30
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN0923-7534